Current opinion on the clinical approach to the diagnosis of mitochondrial disease

International Journal of Gerontology

Volumn 1, Issue 1, 2007, Pages 22-30

  Thajeb, Peterus ^a,b,c   Dai, Dao Fu ^d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Mitochondrial disease; Mitochondrial DNA; Mutation; Nuclear DNA; Oxidative phosphorylation

Indexed keywords

AGING; ATAXIA; CEREBELLUM ATROPHY; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL PRACTICE; CREATINE KINASE BLOOD LEVEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FAMILY HISTORY; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; HUMAN; KEARNS SAYRE SYNDROME; KIDNEY FUNCTION TEST; LACTIC ACIDOSIS; LEBER HEREDITARY OPTIC NEUROPATHY; LIVER FUNCTION TEST; MELAS SYNDROME; MENTAL DEFICIENCY; MERRF SYNDROME; MNGIE SYNDROME; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; REVIEW;

EID: 39549100346     PISSN: 18739598     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1873-9598(08)70020-6     Document Type: Review

References (69)

1. Nass MM, Nass S. Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol 1963; 19: 593-611.
2. Anderson S, Bankier AT, Barrell BG, deBruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of human mitochondrial genome. Nature 1981; 290: 457-65.
3. Shapira Y, Harel S, Russell A. Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci 1977; 13: 161-4.
4. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. Disorders of two genomes. In: Harris H, Hirschhorn K, eds. Advances in Human Genetics. New York: Plenum, 1990; 19: 267-330.
5. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-9.
6. DiMauro S, Tonin P, Servidei S. Metabolic myopathies. In: Rowland LP, DiMauro S, eds. Myopathies, Handbook of Clinical Neurology. Amsterdam: Elsevier Science Publishers B.V. 1992; 18: 496-7.
7. Morgan-Hughes JA. Mitochondrial diseases. in: Engel AG, Franzini-Armstrong C, eds. Myology, vol. 2, 2nd edition. New York: McGraw-Hill, 1994; 1622-3.
8. Luft R, Ikkos D, Palmieri G, Emster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962; 41: 1776-804.
9. DiMauro S, Gurgel-Giannetti J. The expanding phenotype of mitochondrial myopathy. Curr Opin Neurol 2005; 18: 538-42.
10. Schapira AH, Cooper JM, Morgan-Hughes JA, Landon DN, Clark JB. Mitochondrial myopathy with a defect of mitochondrial protein transport. N Engl J Med 1990; 323: 37-42.
11. Thajeb P, Dai D, Chiang MF, Shyu WC. Genotype-phenotype correlation of maternally inherited disorders due to mutations in mitochondrial DNA. Taiwan J Obstet Gynecol 2006; 45: 201-7.
12. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-9.
13. Wallace DC, Lott MT, Brown MD, Kerstann K. Mitochondria and neuroophthalmologic diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of inherited Disease, 8th edition. New York: McGraw-Hill, 2001; 2: 2425-509.
14. Liou CW, Huang CC, Chee EC, Jong YJ, Tsai JL, Pang CY, et al. MELAS syndrome: correlation between clinical features and molecular genetic analysis. Acta Neurol Scand 1994; 90: 354-9.
15. Thajeb P, Lee HC, Pang CY, Jeng CM, Huang SF, Wei YH. Phenotypic heterogeneity in a Chinese family with mitochondrial disease and A3243G mutation of mitochondrial DNA. Chin Med J (Taipei) 2000; 63: 71-6.
16. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNALeu(UUR) A to G(3243) mutation. A clinical and genetic study. Brain 1995; 118: 721-34.
17. McFarland R, Taylor RW, Turnbull DM. The neurology of mitochondrial DNA disease. Lancet Neurol 2002; 1: 343-51.
18. Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci USA 1989; 86: 7952-6.
19. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Ophthalmology 1958; 60: 280-9.
20. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of inherited Disease. New York: McGraw-Hill, 1995; 1535-609.
21. Seneca S, Verhelst H, De Meirleir L, Meire F, Ceuterick-De Groote C, Lissens W, et al. A new mitochondrial point mutation in the transfer RNA(Leu) gene in a patient with a clinical phenotype resembling Kearns-Sayre syndrome. Arch Neurol 2001; 58: 1113-8.
22. Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol Genet Metab 2005; 84: 127-36.
23. Moraes CT, Zeviani M, Schon EA, Hickman RO, Vlcek BW, DiMauro S. Mitochondrial DNA deletion in a girl with manifestations of Kearns-Sayre and Lowe syndromes: an example of phenotypic mimicry? Am J Med Genet 1991; 41: 301-5.
24. Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial disease. Am J Hum Genet 1991; 48: 492-501.
25. Servidei S. Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 2004; 14: 107-16.
26. Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet 2002; 39: 162-9.
27. Lev D, Yanoov-Sharav M, Watemberg N, Leshinsky-Silver E, Lerman-Sagie T. White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol 2002; 6: 121-3.
28. Pavlakis SG, Phillips PC, DiMauro S, deVivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.
29. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992; 31: 391-8.
30. Abe K. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004; 63: 2458.
31. Thajeb P, Huang KM, Chi EY, Shih CC, Su ML, Huang JS. Koshevnikov syndrome in a patient with MELAS plus syndrome: electron microscopic and neuroimage studies. Chin Med J (Beijing) 1997-1110: 726-30.
32. Finsterer J, Kopsa W. Basal ganglia calcification in mitochondrial disorders. Metab Brain Dis 2005; 20: 219-26.
33. Apostolova LG, White M, Moore SA, Davis PH. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol 2005; 62: 1154-6.
34. Peng NJ, Liu RS, Li JY, et al. Increased cerebral blood flow in MELAS shown by Tc-99m HMPAO brain SPECT. Neuroradiology 2000; 42: 26-9.
35. Thajeb P, Wu MC, Shih BF, Tzen CY, Chiang MF, Yuan RY. Brain SPECT studies in patients with A3243G mutation of the mitochondrial DNA. Ann NY Acad Sci 2005; 1042: 48-54.
36. Tokunago M, Mita S, Sakuta R, Nonaka I, Araki S. increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol 1993; 33: 275-80.
37. Goto Y, Nonaka I, Horai S. A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
38. Ciafaloni E, Ricci E, Servidei S, Shanske S, Silvestri G, Manfredi G, et al. Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome, Neurology 1991; 41: 1663-4.
39. Macmillan C, Lach B, Shoubridge EA. Variable distribution of mutant mitochondrial DNAs tRNA(Leu[3243]) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. Neurology 1993; 43: 1586-90.
40. Fang W, Huang CC, Lee CC, Cheng SY, Pang CY, Wei YH. Ophthalmologic manifestations in MELAS syndrome. Arch Neurol 1993; 50: 977-80.
41. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 1997; 120: 1713-21.
42. Zhang Y, Li JF, Wang FY, Li CX. The study of A3243G and G13513A mitochondria DNA point mutation in patients with cerebral infarction. Chin Med J (Beijing) 2001; 114: 129-35.
43. Tzen CY, Thajeb P, Wu TY, Chen SC. MELAS with point mutations involving tRNALeu (A3243G) and tRNAGlu (14693G). Muscle Nerve 2003; 28: 575-81.
44. Graf WD, Sumi SM, Copass MK, Ojemann LM, Longstreth WT, Jr, Shanske S, et al. Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA. Ann Neurol 1993; 33: 640-5.
45. Silvestri G, Ciafaloni E, Santorelli FM, Shanske S, Servidei S, Graf WD, et al. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology 1993; 43: 1200-6.
46. Tanno Y, Yoneda M, Tanaka K, Kondo R, Hozumi I, Wakabayashi K, et al. Uniform tissue distribution of tRNA(Lys) mutation in mitochondrial DNA in MERRF patients. Neurology 1993; 43: 1198-200.
47. Lys mutation. Cell 1990; 61: 931-7.
48. Zeviani M, Gellera C, Antozzi C, Rimoldi M, Morandi L, Villani F, et al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR). Lancet 1991; 338: 143-7.
49. Thajeb P, Ma YS, Tzen CY, Chuang CK, Wu TY, Chen SC, et al. Oculopharyngeal somatic myopathy in a patient with a novel large-scale 3399bp deletion and a homoplasmic T5814C transition of the mitochondrial DNA. Clin Neurol Neurosurg 2006; 108: 407-10.
50. Mattiazzi M, Vijayvergiya C, Gajewski CD, DeVivo DC, Lenaz G, Wiedmann M, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 2004; 13: 869-79.
51. Pulkes T, Eunson L, Patterson V, Siddiqui A, Wood NW, Nelson IP, et al. The mitochondrial DNA G13513A transition in ND5 is associated with LHON/ MELAS overlap syndrome and may be a frequent cause of MELAS. Ann Neurol 1999; 46: 916-9.
52. Campos Y, Martin MA, Lorenzo G, Aparicio M, Cabello A, Arenas J. Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA. Muscle Nerve 1996; 19: 187-90.
53. Hsu CC, Chuang YH, Tsai JL, Jong HJ, Shen YY, Huang HL, et al. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol Scand 1995; 92: 252-5.
54. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-7.
55. Said G, Lacroix C, Plante-Bordeneuve V, Messing B, Slama A, Crenn P, et al. Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation. J Neurol 2005; 252: 655-62.
56. Vissing J, Ravn K, Danielsen ER, Duno M, Wibrand F, Wevers RA, et al. Multiple mtDNA deletions with features of MNGIE. Neurology 2002; 59: 926-9.
57. Wallace DC, Lott MT. Mitochondrial genes in degenerative diseases, cancer and aging. In: Rimon DL, Connor JM, Pyeritz RE, Korf BR, eds. Emery and Rimons's Principles and Practice of Medical Genetics, 4th edition. London: Churchill Livingstone, 2002; 1: 299-409.
58. Hammans SR, Sweeney MG, Brockington M, Lennox GG, Lawton NF, Kennedy CR, et al. The mitochondrial DNA transfer RNA (Lys) A to G (3243) mutation and the syndrome of myoclonic epilepsy with ragged-red fibers (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993; 116: 617-32.
59. Tanno Y, Yoneda M, Tanaka K, Tanaka H, Yamazaki M, Nishizawa M, et al. Quantitation of heteroplasmy of mitochondrial tRNA(Leu(UUR)) gene using PCR-SSCP. Muscle Nerve 1995; 18: 1390-7.
60. Kobayashi Y, Ichihashi K, Ohta S, Nihei K, Kagawa Y, Yanagisawa M, et al. The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) were selectively amplified through generations. J Inherit Metab Dis 1992; 15: 803-8.
61. Parry A, Matthews PM. Roles for imaging in understanding the pathophysiology, clinical evaluation, and management of patients with mitochondrial disease. J Neuroimaging 2003; 13: 293-302.
62. Engel WK, Cunningham GC. Rapid examination of muscle tissue: an improved trichrome method for fresh-frozen biopsy sections. Neurology 1963; 13: 919-23.
63. Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 1989; 86: 2379-82.
64. Van Maldergem L, Trijbels F, DiMauro S, Sindelar PJ, Musumeci O, Janssen A, et al. Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 2002; 52: 750-4.
65. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990; 322: 1098-105.
66. Hanzlikova V, Schiaffino S. Mitochondrial changes in ischemic skeletal muscle. J Ultrastruct Res 1977; 60: 121-33.
67. Shy GM, Gonatas NK. Human myopathy with giant abnormal mitochondria. Science 1964; 145: 493-6.
68. Shy GM, Gonatas NK, Perez M. Two childhood myopathies with abnormal mitochondria: I. Megoconial myopathy. II. Pleoconial myopathy. Brain 1966; 89: 133-58.
69. Bonilla E, Schotland DL, DiMauro S, Aldover B, Electron cytochemistry of crystalline inclusions in human skeletal muscle mitochondria. J Ultrastruct Res 1975; 51: 404-8.